Jianjun Han

机构：Hebei University of Engineering, Panyu District Central Hospital, Affiliated Hospital of Hebei University, Chinese Journal of Integrated Traditional and Western Medicine, Shandong First Medical University, Guangzhou Medical University · ORCID：0000-0003-2885-3470

发表论文 31 篇 · 总被引 303 次 · h-index 11

代表论文

• Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway (2018 · Bosnian Journal of Basic Medical Sciences · 被引 56)
• FAM49B promotes breast cancer proliferation, metastasis, and chemoresistance by stabilizing ELAVL1 protein and regulating downstream Rab10/TLR4 pathway (2021 · Cancer Cell International · 被引 31)
• Circ_0109291 Promotes Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase ABCB1 Expression (2020 · Cancer Biotherapy and Radiopharmaceuticals · 被引 31)
• TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway (2019 · Cancer Cell International · 被引 29)
• RILPL2 regulates breast cancer proliferation, metastasis, and chemoresistance via the TUBB3/PTEN pathway. (2019 · PubMed · 被引 18)
• MiR-30c facilitates natural killer cell cytotoxicity to lung cancer through targeting GALNT7 (2022 · Genes & Genomics · 被引 16)